Gene delivery and gene therapy of prostate cancer.

about

Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment.Production, Characterization and Synthetic Application of a Purine Nucleoside Phosphorylase fromAeromonas hydrophila

P2860

Q39973056-5B18B6F5-A20E-4E81-8836-8BD78E3D6E4F Q56036127-321DCE3A-7D4B-4970-919D-77F66F8A2BAA

P2860

Gene delivery and gene therapy of prostate cancer.

Item

http://www.wikidata.org/entity/Q36349678

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Gene delivery and gene therapy of prostate cancer.

@ast

Gene delivery and gene therapy of prostate cancer.

@en

type

Item

label

Gene delivery and gene therapy of prostate cancer.

@ast

Gene delivery and gene therapy of prostate cancer.

@en

prefLabel

Gene delivery and gene therapy of prostate cancer.

@ast

Gene delivery and gene therapy of prostate cancer.

@en

P1476

Gene delivery and gene therapy of prostate cancer.

@en

P2093

Donald J Buchsbaum

http://www.w3.org/2001/XMLSchema#string

Sergey A Kaliberov

http://www.w3.org/2001/XMLSchema#string

P2860

mRTVP-1, a novel p53 target gene with proapoptotic activities.

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways

Signal transduction in prostate cancer progression.

Drug-targeting strategies for prostate cancer.

Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.

Recombinant viruses as a tool for therapeutic vaccination against human cancers.

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.

Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer.

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.

P304

37-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.3.1.37

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16370939

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

Gene delivery and gene therapy of prostate cancer.

about

P2860

P2860

Gene delivery and gene therapy of prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921